Screener
Actinium Pharmaceuticals ATNM Q1 2026 earnings
Reported May 8, 2026 · After market close
EPS-$0.18Beat by $0.04
Revenue estimate$2.5M
EPS estimate-$0.22
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$1.2M
EPS estimate-$0.25
Versus estimates
Diluted EPS
FAQ
- When did Actinium Pharmaceuticals report Q1 2026 earnings?
- Actinium Pharmaceuticals (ATNM) reported Q1 2026 earnings on May 8, 2026 after market close.
- What were Actinium Pharmaceuticals's Q1 2026 revenue and EPS?
- Actinium Pharmaceuticals reported eps of $-0.18 for Q1 2026.
- Did Actinium Pharmaceuticals beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.22 by $0.04.
- How did Actinium Pharmaceuticals's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 64.7% from $-0.51.
- Where can I find Actinium Pharmaceuticals's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001213900-26-053980) directly on SEC EDGAR. The filing index links above go to sec.gov.
